Controlling T cell–tumor cell interaction with a biomimetic physical barrier for cancer immunotherapy
- Yuxuan Zhang
- Jinjin Wang
- Guangchao Qing
- Yongchao Wang
- Xianlei Li
- Ting Luo
- Yi-Feng Wang
- Lu Liu
- Yufei Wang
- Qiankun Ni
- Shuyi Li
- Junge Chen
- Fangzhou Li
- Weisheng Guo
- Jinchao Zhang
- Ningqiang Gong
- Xing-Jie Liang
2025-07-08
Cancer immunotherapy has shown tremendous promise in various cancers. However, current strategies, such as immune checkpoint blockade, primarily restore exhausted T cells but provide only transient efficacy, as the rapid clearance of antibodies. Their limited durability is further hindered by persistent T cell-tumor cell interactions that accelerate T cell exhaustion. To prevent T cells from sustained exposure to these interactions, we present a hydrogel-based biomimetic physical barrier (BPB) here to create a “protective zone” for T cells. The BPB temporarily blocks T cell-tumor cell interactions and shields T cells from inactivation and exhaustion, allowing them to accumulate and maintain their functional activity in the tumor microenvironment. After sufficient T cell accumulation, the dismantling of BPB triggered by near-infrared light irradiation-induced gel-sol transition will restore the interaction between T cells and tumor cells. This controlled re-exposure allows the accumulated T cells to attack the tumor cells in a more activated and anti-exhaustion state, maximizing their tumor-killing potential. Moreover, BPB not only enhances immediate tumor regression but also triggers systemic immune activation and durable memory responses, enabling long-term protection against tumor rechallenge and effective control of multifocal tumors. Collectively, our BPB for modulating the T cell-tumor cell interaction has great prospects for advancing cancer immunotherapy.